Novartis AG vs Quantum Computing Inc — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while Quantum Computing Inc trades at $8.97 (market cap $2.03B). The key difference: Novartis AG is far larger — about 145.5× Quantum Computing Inc's market cap, and Novartis AG pays a 3.07% dividend while Quantum Computing Inc pays none. Which is the better fit depends on your goals.
| NVS | QUBT | |
|---|---|---|
Market Cap | $295.37B | $2.03B |
Sector | Health | Technology |
52-Week High | $168.62 | $24.62 |
52-Week Low | $119.31 | $6.31 |
Enterprise Value | $336.69B | $1.09B |
Dividend Yield | 3.07% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →